Culture negativity of the pathogens hinders prompt diagnosis, especially in endophthalmitis, which further delays treatment initiation and puts visual recovery at stake. With nearly 50% of samples being culture negative the world over
19,20 and more than 70% of culture-negative endophthalmitis cases in our institute alone,
5 there is an earnest need to develop an alternative diagnostic method targeting culture-negative cases. EVs have gained significant attention in the field of diagnostics because of their potential as biomarkers for various diseases. In our previous in vitro and in vivo studies, we reported that calpain-2 was upregulated, whereas C8α was present exclusively in the EVs of infected samples.
11–13 In this study, we validated these markers in direct vitreous and EVs isolated from the vitreous samples diagnosed with bacterial endophthalmitis. A total of 70 samples from 35 patients (10 vitreous controls, 10 EV controls, 15 culture positive vitreous, 15 EVs from culture positive, 10 culture negative vitreous, and 10 EVs from culture-negative samples) were used in this study. After the EV isolation, expression levels of calpain-2 and C8α was assessed by enzyme-linked immunosorbent assay and ROC curve was generated to evaluate their diagnostic potential in bacterial endophthalmitis especially for culture negative cases. The results showed that the EV-calpain-2 levels (ng/mL) were significantly higher in control (4.54 ± 1.94) in comparison to culture negative (0.94 ± 0.64) samples and the similar level of expression was observed in direct vitreous of control (4.92 ± 0.59) and culture negative (1.23 ± 0.76) samples.
Interestingly, the results were not in accordance with our in vivo studies where the calpain-2 levels were higher in infection when compared to control. Calpain-2 is a calcium-activated protease that is majorly involved in activation of NF-κB pathway playing a major role in acute inflammation.
21 Additionally, they are also associated with neurodegeneration and lower levels of calpain-2 is linked to neuroprotection. We hypothesize that the lower cargo of calpain-2 in the EVs and in vitreous could attribute to its neuroprotective role in the humans.
22 Furthermore, regulating excess inflammation could also preserve retinal architecture thereby preventing vision loss. Complement component is a core part of immune system, and C8α is a part of MAC that is responsible for pathogen killing and controlling infection.
23 Although EV-C8α levels were significantly higher in culture-negative (31.20 ± 9.8) when compared to control (4.5 ± 2.8), in the direct vitreous, however, the difference between culture-negative (0.25 ± 0.7) and control (1.20 ± 1.20) was not significant. As reported by Boukouris et al. (2015)
24, the body fluids consist of diverse and vast majority of the proteins which makes it increasingly difficult to assess biomarkers. Although this discrepancy has no reasoning yet, the extracellular vesicles cargo is relatively smaller which explains the differential C8α level in vitreous and EVs and this highlights the potential of EVs in diagnosis of culture negative endophthalmitis. Although, several complement proteins have been explored as potential biomarkers for ocular diseases, such as C3 upregulation is strongly associated with age-related macular degeneration, and C7 is reported to discern diabetic retinopathy cases with control; however, C8 is not explored in any ocular diseases especially in infections. The higher expression of C8α could signify the active participation of the host immune system in resolving the infection. Additionally, the significant differential expression of both the proteins (calpain-2 and C8α) in the EVs of culture-negative and control samples further promises their potential to be developed as a diagnostic marker. Another noteworthy finding in our in vivo study of
S. aureus endophthalmitis model was the downregulation of complement component 5 (C5), and the breakdown of which into C5a and C5b is a critical step for the initiation of MAC.
23,25–28 However, in this study we did not find any significant difference in the C8α expression in
S. aureus endophthalmitis vitreous samples versus any other bacterial vitreous samples.
Deshmukh et al.
29 have reported the potential of cytokines as biomarkers for infectious culture negative endophthalmitis. However, instead of a panel of cytokines, assessment of single protein EV-C8α is a good alternative since it is relatively cost effective, rapid and feasible to predict the presence of endophthalmitis in over 70% of the cases. The limitation of our study is the inclusion of lesser sample size because of which the subgroup analysis of protein (calpain-2 and C8α) expression levels of different bacterial species could not be performed because, when grouped, the sample size is statistically inadequate. Analysis of protein level in gram-positive versus gram-negative revealed a slight increase of C8α in the gram-negative, although there was no significant difference in the expression levels of both proteins. Additionally, performing Western blot would have further validated the specificity of the C8α antibody; however, because of the limited availability of the patient vitreous samples, this additional step could not be performed. Overall, EV has been a swiftly emerging field, and research has extended to every possible area to use its diagnostic and therapeutic potential. Bacterial endophthalmitis, especially culture-negative cases, have seen a dramatic increase because of increasing use of empirical therapy and lack of ocular microbiology facilities. Because of its rapid manifestation, endophthalmitis is considered an ophthalmic emergency, and the extensive involvement of the retina often leads to irreversible vision loss. A study at our institute previously reported that more than 70% of total endophthalmitis cases are culture negative, which delays diagnosis further.
5 Our study highlights that with sensitivity and specificity of 1 with 95% class interval, EV-C8α could be a promising quick diagnostic marker for culture-negative bacterial endophthalmitis. Although with current advancements, isolation of pure EVs is still challenging and time consuming, with the rapid advancement of research on EVs, especially exosomes, it is not too far to fully realize and use their potential in the clinics.